Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. COHR

Go back to Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies
(NASDAQ: FULC) Delayed: 3.80 +0.04 (1.06%)
Previous Close $3.76    52 Week High $ 
Open $3.80    52 Week Low $ 
Day High $3.80    P/E N/A 
Day Low $3.75    EPS $ 
Volume 731,515